TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23998546

Group type: EXPERIMENTAL
Intervention: CCTA-guided strategy
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 600
Study: 21244474

Group type: EXPERIMENTAL
Intervention: Pitavastatin 2 mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 31
Study: 19523206

Group type: EXPERIMENTAL
Intervention: BMI >= 85th percentile, self-perceived as obese, expressed body dissatisfaction
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Boys trying to lose weight
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Overall adolescents
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Girls with BMI >= 95th percentile
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Girls with BMI >= 85th percentile
Number of subjects: 448
Study: 17802784

Group type: EXPERIMENTAL
Intervention: 4 courses of 7+3+VP‐16 and 5 courses of maintenance therapy (7+3 with thioguanin)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: 2 courses of 7+3+VP‐16, 2 courses 7+3, maintenance‐‐5 courses 7+3 with thioguanin
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: 2 courses of 7+3+VP‐16, 2 HAD courses, treatment discontinuation
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Recurrence-free survival
Number of subjects: 354
Study: 14749191

Group type: EXPERIMENTAL
Intervention: IDET
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sham treatment (placebo)
Number of subjects: 64
Study: 11816441

Group type: EXPERIMENTAL
Intervention: Chloroquine for 3 days (CQ, Group I)
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Quinine sulphate for 3 days followed by single-dose sulfadoxine-pyrimethamine (Q3 + SP, Group II)
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Quinine for 7 days (Q7, Group III)
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Mefloquine 20 mg/kg single dose (MEF, Group IV)
Number of subjects: 413
Study: 9788686

Group type: EXPERIMENTAL
Intervention: 0.025% azelastine eye-drops
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: 0.05% azelastine eye-drops
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 7625341

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (3 sessions of 45 minutes/week at 65% VO2max)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no aerobic exercise)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (EX group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (NX group)
Number of subjects: 30
Study: 2582767

Group type: EXPERIMENTAL
Intervention: Laparoscopic Falope ring application
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Bipolar electrocoagulation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Hulka clip application
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pomeroy tubal ligation via minilaparotomy
Number of subjects: 100
Study: 952756

Group type: COMPARATOR
Intervention: Salicylic acid in aqueous cream or white soft paraffin at concentrations of 2-12% applied to normal skin.
Number of subjects: 23
Study: 30311680

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hypopressive exercises (HE)
Number of subjects: 100
Study: 28051893

Group type: EXPERIMENTAL
Intervention: Training with a standardized patient
Number of subjects: 49

Group type: COMPARATOR
Intervention: Training on a high-fidelity mannequin
Number of subjects: 49
Study: 25078385

Group type: EXPERIMENTAL
Intervention: Intravenous lignocaine (1.5mg/kg bolus at intubation followed by 1.5mg/kg/h infusion until 1h post-surgery)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Intravenous lignocaine
Number of subjects: 134

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 134
Study: 23422351

Group type: EXPERIMENTAL
Intervention: Maintenance Counseling group (n = 64) received exercise counseling via telephone for 6 months, along with print materials and feedback reports.
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Maintenance Counseling group (n = 64) received exercise counseling via telephone for 6 months.
Number of subjects: 130

Group type: COMPARATOR
Intervention: Contact Control group (n = 66) received contact control.
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Both groups were assessed for overall mental health.
Number of subjects: 130
Study: 21555790

Group type: EXPERIMENTAL
Intervention: Drowsy/Sleeping state
Number of subjects: 100

Group type: COMPARATOR
Intervention: Awake state
Number of subjects: 100
Study: 19969208

Group type: EXPERIMENTAL
Intervention: +3.0 D IOL
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: +4.0 D IOL
Number of subjects: 279
Study: 17429917

Group type: EXPERIMENTAL
Intervention: Swaddled condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-swaddled condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-swaddled infants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Swaddled infants (both conditions)
Number of subjects: 0
Study: 15533341

Group type: EXPERIMENTAL
Intervention: Midluteal phase endometrial sampling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Late luteal phase endometrial sampling
Number of subjects: 0
Study: 12029922

Group type: EXPERIMENTAL
Intervention: School-based asthma clinic project
Number of subjects: 0
Study: 9040543

Group type: EXPERIMENTAL
Intervention: Energy-dense milk cereal formula (5 kJ/g, 11% protein)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (milk-cereal formula with 2.5 kJ/g, 11% protein)
Number of subjects: 75
Study: 7944321

Group type: EXPERIMENTAL
Intervention: Preadmission teaching brochures
Number of subjects: 38
Study: 3059793

Group type: EXPERIMENTAL
Intervention: Instant bean flakes
Number of subjects: 6

Group type: COMPARATOR
Intervention: Potato-flakes bran
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Both meals
Number of subjects: 6
Study: 30590877

Group type: EXPERIMENTAL
Intervention: 1.2-g LCPUFA-ω3 daily for 3 months
Number of subjects: 366

Group type: COMPARATOR
Intervention: 1-g sunflower oil daily for 3 months (Control)
Number of subjects: 366
Study: 28825998

Group type: EXPERIMENTAL
Intervention: Expert system feedback tool
Number of subjects: 27
Study: 25399016

Group type: EXPERIMENTAL
Intervention: First home BP measurement
Number of subjects: 4802

Group type: EXPERIMENTAL
Intervention: Multiple home BP measurement days (1-7 days)
Number of subjects: 4802

Group type: EXPERIMENTAL
Intervention: Single home BP measurement
Number of subjects: 4802

Group type: EXPERIMENTAL
Intervention: Seven home measurement days
Number of subjects: 4802

Group type: EXPERIMENTAL
Intervention: Masked hypertension
Number of subjects: 4802

Group type: EXPERIMENTAL
Intervention: White-coat hypertension
Number of subjects: 4802
Study: 23306796

Group type: EXPERIMENTAL
Intervention: Radical antrum resection (RA group)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Preserved antrum (PA group, control)
Number of subjects: 12
Study: 20801942

Group type: EXPERIMENTAL
Intervention: Systematic treatment programme (experimental group)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Routine occupational therapy (control group)
Number of subjects: 15
Study: 18455411

Group type: EXPERIMENTAL
Intervention: Heart-lung machine (HLM)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Non-heart-lung machine (non-HLM)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Overall psychological score
Number of subjects: 32
Study: 17375319

Group type: EXPERIMENTAL
Intervention: Early onset cognitive behavioural therapy
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control group (no early onset cognitive behavioural therapy)
Number of subjects: 171
Study: 14737168

Group type: EXPERIMENTAL
Intervention: 8 hours of nocturnal sleep
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nocturnal wakefulness
Number of subjects: 0

Group type: COMPARATOR
Intervention: Daytime wakefulness
Number of subjects: 0
Study: 11890581

Group type: EXPERIMENTAL
Intervention: Intervention (home hazard assessment, educational strategy, installation of safety devices)
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Intervention (advice on modifying specific hazards)
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: General education message
Number of subjects: 570
Study: 9597214

Group type: EXPERIMENTAL
Intervention: Arrow (FlexTip Plus) epidural catheter
Number of subjects: 200

Group type: COMPARATOR
Intervention: Portex epidural catheter
Number of subjects: 200
Study: 8163375

Group type: EXPERIMENTAL
Intervention: Guided imagery training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Biofeedback
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 3796926

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 52

Group type: COMPARATOR
Intervention: Terbutaline
Number of subjects: 52
Study: 31424399

Group type: EXPERIMENTAL
Intervention: Indoor therapeutic garden (TG)
Number of subjects: 163
Study: 29029087

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 114

Group type: COMPARATOR
Intervention: Olmesartan
Number of subjects: 114
Study: 26903197

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (PRD)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Saline (PRS)
Number of subjects: 64
Study: 25386453

Group type: EXPERIMENTAL
Intervention: Ivermectin (200 μg/kg body weight) oral in a single dose
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Topical Permethrin 5% cream single application
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Topical gamma benzene hexachloride (GBHC) lotion 1% single application
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Topical Benzyl benzoate (BB) lotion 25% single application
Number of subjects: 240
Study: 23033919

Group type: EXPERIMENTAL
Intervention: Supplement (120 mg of N-oleyl-phosphatidyl-ethanolamine and 105 mg of epigallocatechin-3-gallate)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Supplement
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 19944377

Group type: EXPERIMENTAL
Intervention: Pain Education Program (PEP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine clinical care (Control)
Number of subjects: 40
Study: 17324047

Group type: EXPERIMENTAL
Intervention: 30-mg cortisol
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 14967159

Group type: EXPERIMENTAL
Intervention: Antioxidants (vitamins C and E, beta-carotene, selenium) with methimazole
Number of subjects: 57

Group type: COMPARATOR
Intervention: Methimazole only
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Antioxidants with methimazole
Number of subjects: 57
Study: 11458213

Group type: EXPERIMENTAL
Intervention: Nasal irrigation with bulb syringe
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Nasal irrigation with nasal irrigation pot
Number of subjects: 150

Group type: COMPARATOR
Intervention: Reflexology massage
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: All interventions (bulb syringe, nasal irrigation pot, reflexology massage)
Number of subjects: 150
Study: 9568442

Group type: EXPERIMENTAL
Intervention: Eradication therapy for H. pylori
Number of subjects: 236

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study: 8092559

Group type: EXPERIMENTAL
Intervention: Intranasal fluticasone propionate 200 micrograms once daily
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Intranasal fluticasone propionate 100 micrograms twice daily
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Intranasal fluticasone propionate (both dosages)
Number of subjects: 365

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Intranasal fluticasone propionate (200 micrograms once daily or 100 micrograms twice daily)
Number of subjects: 365
Study: 2964468

Group type: EXPERIMENTAL
Intervention: Life review process (experimental group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Friendly visit (control group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment (no-treatment group)
Number of subjects: 60
Study: 31774604

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 40
Study: 31188852

Group type: EXPERIMENTAL
Intervention: Alcohol intervention trials
Number of subjects: 27
Study: 28375713

Group type: EXPERIMENTAL
Intervention: 25G spinal needle
Number of subjects: 84

Group type: COMPARATOR
Intervention: 29G spinal needle
Number of subjects: 84
Study: 25885543

Group type: EXPERIMENTAL
Intervention: Qishe pill (3.75 grams)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Qishe pill (7.5 grams)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Qishe pill (15 grams)
Number of subjects: 108
Study: 24006953

Group type: EXPERIMENTAL
Intervention: Cold chain rotigotine patch (2 mg/24 h) in SP951
Number of subjects: 158

Group type: COMPARATOR
Intervention: Original rotigotine patch (2 mg/24 h) in SP951
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Room temperature stable rotigotine patch (2 mg/24 h) in SP0987
Number of subjects: 158

Group type: COMPARATOR
Intervention: Cold chain rotigotine patch (2 mg/24 h) in SP0987
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Cold chain rotigotine patch (8 mg/24 h) in SP1066
Number of subjects: 158

Group type: COMPARATOR
Intervention: Room temperature stable rotigotine patch (8 mg/24 h) in SP1066
Number of subjects: 158
Study: 21835022

Group type: EXPERIMENTAL
Intervention: True diet (n = 84)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Sham diet (n = 83)
Number of subjects: 167
Study: 19637968

Group type: EXPERIMENTAL
Intervention: 7.5% hypertonic saline plus 6% dextran70 (HSD)
Number of subjects: 64

Group type: COMPARATOR
Intervention: 0.9% normal saline (NS)
Number of subjects: 64
Study: 17460547

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 174
Study: 15181134

Group type: EXPERIMENTAL
Intervention: Thyroglobulin (Tg) levels measured just before (131)I ablative therapy (Tg1)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Thyroglobulin (Tg) levels measured 6-12 months later (Tg2)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Disease progression
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Progression-free survival rates
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Univariate analysis of disease progression
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Multivariate analysis of disease progression
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Initial parameters for disease progression
Number of subjects: 212
Study: 10552274

Group type: EXPERIMENTAL
Intervention: 5.5% carbohydrate (CHO) solution
Number of subjects: 10

Group type: COMPARATOR
Intervention: Artificially sweetened placebo (Pl)
Number of subjects: 10
Study: 9323144

Group type: EXPERIMENTAL
Intervention: Concurrent chemotherapy and continuous-course radiotherapy (Arm B)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Radiotherapy alone (Arm A)
Number of subjects: 100
Study: 8457239

Group type: EXPERIMENTAL
Intervention: Nimesulide (200 mg suppository, t.i.d. for 2 days)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Paracetamol (500 mg suppository, t.i.d. for 2 days)
Number of subjects: 39
Study: 3533007

Group type: EXPERIMENTAL
Intervention: Transparent moisture vapor permeable dressing (MVP)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Gauze and tape dressing
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both dressings
Number of subjects: 48
Study: 30397939

Group type: EXPERIMENTAL
Intervention: 1-day Cefuroxime prophylaxis
Number of subjects: 450

Group type: COMPARATOR
Intervention: 3-day Cefuroxime prophylaxis
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 450
Study: 26423100

Group type: EXPERIMENTAL
Intervention: Active-play video games (Xbox 360 with Kinect)
Number of subjects: 16
Study: 25044909

Group type: EXPERIMENTAL
Intervention: Blueberry-containing baked products
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Unprocessed blueberry drink
Number of subjects: 10

Group type: COMPARATOR
Intervention: Matched control baked products
Number of subjects: 10
Study: 22452233

Group type: EXPERIMENTAL
Intervention: Tight necktie
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Loosening necktie
Number of subjects: 40

Group type: COMPARATOR
Intervention: No necktie
Number of subjects: 40
Study: 20405515

Group type: EXPERIMENTAL
Intervention: Methylprednisolone monotherapy (MpMT) (32 mg/m2/day IV x 3 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (children without peripheral blasts)
Number of subjects: 30
Study: 18184901

Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 15781794

Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (MBP) with Soffodex
Number of subjects: 329

Group type: COMPARATOR
Intervention: Non-mechanical bowel preparation (non-MBP)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (MBP)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 329
Study: 12557835

Group type: EXPERIMENTAL
Intervention: Mefloquine (MQ)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Mefloquine-artesunate (MQ-AS)
Number of subjects: 115
Study: 10943959

Group type: EXPERIMENTAL
Intervention: Rice‐ORS (R‐ORS)
Number of subjects: 466

Group type: COMPARATOR
Intervention: Glucose‐ORS (G‐ORS)
Number of subjects: 466
Study: 8922914

Group type: EXPERIMENTAL
Intervention: Group-based stress management training (10-week relaxation-based programme)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal care (control group)
Number of subjects: 100
Study: 1583307

Group type: EXPERIMENTAL
Intervention: RU 486 (200 mg orally, 48 hours before Sulprostone injection)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no RU 486)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: RU 486 treatment
Number of subjects: 50
Study: 3931509

Group type: EXPERIMENTAL
Intervention: Flurbiprofen
Number of subjects: 62

Group type: COMPARATOR
Intervention: Antihistamine
Number of subjects: 62
Study: 31806216

Group type: EXPERIMENTAL
Intervention: Dabigatran dual therapy (110 mg twice daily)
Number of subjects: 2725

Group type: EXPERIMENTAL
Intervention: Dabigatran dual therapy (150 mg twice daily)
Number of subjects: 2725

Group type: COMPARATOR
Intervention: Warfarin triple therapy
Number of subjects: 2725
Study: 29506909

Group type: EXPERIMENTAL
Intervention: High-fat diet (HFD) containing 45% fat for 6 weeks
Number of subjects: 92
Study: 27367614

Group type: EXPERIMENTAL
Intervention: Technology-based tools combined with phone-based intervention (TECH + PHONE)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard self-monitoring tools (ST)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Technology-based self-monitoring tools (TECH)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Technology-based self-monitoring tools (TECH) and Technology-based tools combined with phone-based intervention (TECH + PHONE)
Number of subjects: 80
Study: 25380994

Group type: EXPERIMENTAL
Intervention: Clinic-based lay health workers (LHWs) supporting hypertension management in intervention clinics.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care in control clinics.
Number of subjects: 0
Study: 23348641

Group type: EXPERIMENTAL
Intervention: Deep sedation (G1) with propofol (1mg/kg) and continuous infusion of propofol (25‐50mg/kg/min) and remifentanil (0.01‐0.05 mg / kg / min)
Number of subjects: 32

Group type: COMPARATOR
Intervention: General anesthesia (G2) with propofol (2mg/kg) and continuous infusion of propofol (60‐100mg/kg/min) and remifentanil (0.06 to 0.1g/kg/min)
Number of subjects: 32
Study: 20486868

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) for 6 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) for 6 months in women without RAAS blockade
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) for 6 months in women with RAAS blockade
Number of subjects: 20
Study: 19064745

Group type: EXPERIMENTAL
Intervention: ethyl‐EPA, 1 g twice a day
Number of subjects: 316

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: ethyl‐EPA (open-label phase)
Number of subjects: 316
Study: 15955148

Group type: EXPERIMENTAL
Intervention: Incentive spirometry (IS) for 2 months with medical treatment
Number of subjects: 27

Group type: COMPARATOR
Intervention: Medical treatment only
Number of subjects: 27
Study: 11133786

Group type: EXPERIMENTAL
Intervention: Active drop condition (voluntary interaction with vestibulo-collic reflex)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Passive drop condition (no voluntary interaction)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Post-surgery condition (after selective peripheral denervation of neck muscles)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Somatosensory/auditory voluntary reaction times in SCM
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Latency of the startle reflex
Number of subjects: 24
Study: 9562208

Group type: EXPERIMENTAL
Intervention: Fluoxetine plus Mianserin
Number of subjects: 34

Group type: COMPARATOR
Intervention: Fluoxetine plus Placebo
Number of subjects: 34
Study: 8572086

Group type: EXPERIMENTAL
Intervention: Ineraid cochlear implant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Apical cochleostomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Computed tomography and exploratory cochleotomy
Number of subjects: 0
Study: 3277608

Group type: EXPERIMENTAL
Intervention: 200,000 IU of vitamin A supplementation
Number of subjects: 25000

Group type: COMPARATOR
Intervention: Concurrent controls
Number of subjects: 25000

Group type: EXPERIMENTAL
Intervention: Clinical indicators
Number of subjects: 25000